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Case Presentation
We present three separate cases in which
patients came to our clinic believing that they
needed treatment for metal toxicity. In each
case, the patient’s beliefs were due to the
results of hair analysis and other diagnostic
tests. 
Case 1. Patient 1, a 41-year-old white
female, came to our clinic because she was
concerned about heavy metal intoxication,
particularly mercury. She was an organiza-
tional consultant with a Ph.D. in organiza-
tional behavior, and she was a self-described
“hands-on healer.” She stated that she had
been sick for the last 10 years, she con-
stantly felt very tired and suffered from
body aches and joint pain, she constantly
felt as though she was getting the flu, and
she had noticed significant deterioration in
her mental functioning. Her past occupa-
tional history revealed no potential sources
of mercury exposure; other possible sources
of exposure included frequent seafood con-
sumption and 12 mercury amalgam dental
fillings. She reported that her past medical
history was significant for depression, anxi-
ety, and Wilson’s syndrome. She did not
drink alcohol to excess or smoke tobacco.
Her medications were nefazodone, dex-
troamphetamine, estrogen/testosterone
combination, testosterone, progesterone, and
vitamins and supplements. A physical exami-
nation of the patient, including a neurologic
examination, was within normal limits. The
patient stated that she had no concern about
environmental causes of her symptoms until
a specialist in alternative medicine, who felt
her symptoms suggested metal toxicity,
ordered an elemental hair analysis, which
screened for 34 different elements described
as “toxic,” “nutritional” and “other.” The
report did not indicate which method was
used to measure these analytes in the hair.
The hair analysis report indicated a mercury
level of 2.79 ppm (the laboratory considered
0–0.95 ppm to be within normal limits).
The same health care provider also ordered a
urine test, which involved oral administra-
tion of 500 mg of meso-2,3-dimercaptosuc-
cinic acid (DMSA) and urine collection over
an unspeciﬁed period of time. This resulted
in a urine mercury level of 11.5 µg/g of crea-
tinine. The other metals collected in the
urine were lead, arsenic, cadmium, and
nickel. The laboratory reported that all met-
als in the urine were within normal limits,
except mercury, which was elevated. The
patient came to our clinic requesting treat-
ment for mercury toxicity. Based on the hair
analysis and provocative urine test, the patient
was convinced that her symptoms were due to
mercury toxicity. In our clinic, we ordered a
blood test, which revealed a mercury blood
level of 11 µg/L (1.1 µg/100 mL).
Case 2. Patient 2 was a 54-year-old white
female who presented for an evaluation of
elevated mercury levels. She came to our
clinic because she was convinced that she was
suffering from mercury toxicity, which
caused “brain fog” and neccessitated chela-
tion therapy. She stated that she was diag-
nosed with trichomoniasis in January 1990.
The trichomoniasis proved to be Flagyl-resis-
tant, and she was eventually treated with
intravenous medications. According to her
history, the trichomoniasis was ﬁnally cured
in July 1998, but she continued to have vagi-
nal pain. The patient was eventually diag-
nosed with ﬁbromyalgia and chronic fatigue
syndrome. She stated that she had difﬁculty
dealing with stress and had poor mental
functioning, fatigue, and low energy. She
smoked two packs of cigarettes per day and
had done so for 30 years. She had not con-
sumed alcoholic beverages in 10 years and
denied drug use or hobbies associated with
toxic exposure. Her medications were estro-
gen and B12, though no prior history of B12
deﬁciency was noted. Her physical examina-
tion, including neurologic examination, was
within normal limits. She reported no occu-
pational exposures to mercury, but reported
eating tuna and sardines four to six times per
week. Her medical records revealed that
through the years she had extensive nontradi-
tional medical testing, including evaluations
for intestinal parasites and allergy testing for
“snapper, sole, dietary components, and
preservatives.” Over the years, she had at least
four blood mercury tests performed, resulting
in concentrations ranging from 11 µg/L to
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Articles
Hair analysis is used to assess exposure to heavy metals in patients presenting with nonspecific
symptoms and is a commonly used procedure in patients referred to our clinic. We are frequently
called on to evaluate patients who have health-related concerns as a result of hair analysis. Three
patients ﬁrst presented to outside physicians with nonspeciﬁc, multisystemic symptoms. A panel
of analytes was measured in hair, and one or more values were interpreted as elevated. As a result
of the hair analysis and other unconventional diagnostic tests, the patients presented to us believ-
ing they suffered from metal toxicity. In this paper we review the clinical efﬁcacy of this proce-
dure within the context of a patient population with somatic disorders and no clear risk factors
for metal intoxication. We  also review limitations of hair analysis in this setting; these limitations
include patient factors such as low pretest probability of disease and test factors such as the lack of
validation of analytic techniques, the inability to discern between exogenous contaminants and
endogenous toxicants in hair, the variability of analytic procedures, low interlaboratory reliability,
and the increased likelihood of false positive test results in the measurement of panels of analytes.
Key words: hair analysis, lead, mercury, toxicant. Environ Health Perspect 110:433–436 (2002).
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of Public Health, Baltimore, Maryland, USA37 µg/L. In addition, a hair analysis was per-
formed using inductively coupled plasma-
mass spectrometry (ICP-MS). The laboratory
provided results for 39 elements divided into
three categories: “elements regarded as toxic,”
“elements regarded as nutrients,” and “other
elements.” Her results indicated a mercury
level of 3.46 ppm, which the laboratory
reported was more than 2 standard deviations
above the mean. She was also evaluated by
an alternative dentist who placed a probe in
her mouth and concluded that her dental
amalgams were contributing to an elevated
mercury body burden. Based on these
results, the patient started taking DMSA in
the form of Captomer (Thorne Research,
Inc., Dover, ID), available at that time on
the Internet, as recommended by her nutri-
tionist. She also had 12 amalgam fillings
removed and replaced with caps. She pre-
sented with continued concerns about her
elevated mercury levels.
Case 3. Patient 3, a 46-year-old white
male graduate student, came to our clinic
seeking continuation of lead chelation ther-
apy, which he had received from prior physi-
cians. He had been receiving chelation
therapy with intravenous ethylene diamine
tetraacetic acid (EDTA) for the past 2.5 years
from two separate physicians. He stated that
his symptoms began 3 years ago with consti-
pation, gas, and mood swings. His problems
reached a crisis point, and he was diagnosed
with attention deﬁcit hyperactivity disorder,
irritable bowel syndrome, bipolar disease,
and “narcissistic complex.” Finally, a physi-
cian who took a nutritional approach tested
both stool and hair samples. According to the
patient, the stool testing led to the diagnosis
of “ﬁve bugs,” and hair analysis revealed an
elevated lead concentration. A provocative
challenge was reported as “very high” and the
patient stated that he was eventually treated
with intravenous EDTA chelation therapy
two times per week. The patient reported a
dramatic improvement in brain functioning
since treatments; he stated that “my IQ
soared.” His medications were citalopram
and ibuprofen. He did not smoke tobacco,
drink alcohol, or use recreational drugs. His
physical examination was within normal lim-
its. On the first visit, the patient requested
continuation of his chelation therapy. We
requested his laboratory results, which he
sent. The patient’s laboratory results included
hair analyses performed on four different occa-
sions over a 26-month period, all of which
were purported to reveal substantially elevated
lead concentrations. His hair lead-level results
were 27.66 ppm in June 1998 (laboratory
reference range, 0–0.8 ppm), 10.42 ppm in
April 1999 (laboratory reference range,
0–0.8 ppm), 5.3 µg/g in January 2000 (labo-
ratory reference range, 0–2.0 µg/g ), and
8.26 ppm in August 2000 (laboratory refer-
ence range, 0–1.4 ppm). The method of
analysis for three laboratories was not indi-
cated, and the method used by the fourth
laboratory was ICP-MS. The patient also
had three provocative challenges in which
urine was collected for 24 hr and the
amount of lead was measured after adminis-
tration of an unspecified dose of EDTA or
DMSA (it was not indicated which was
used). These test results were 19.3 µg/24 hr
in August 1999, 17 µg/24 hr in November
1999, and 22 µg/24 hr in October 2000. In
addition, the patient had a spot urine analy-
sis for lead as well as a lead concentration in
packed erythrocytes, both of which were
stated to be elevated based on the reference
ranges provided by the laboratories.
Discussion
Many commercial laboratories, chiroprac-
tors, nutrition consultants, practitioners of
alternative medicine, and others promote the
use of hair analysis. Some have set up Web
sites on the Internet that state or imply that
hair analysis can help diagnose a variety of
diseases and conditions, including metal tox-
icity, and that the results of hair analysis can
be used as the basis for taking dietary supple-
ments and other therapies (1). The Web
sites commonly market and sell dietary sup-
plements and other treatments that are pur-
ported to be necessary therapy for patients
with “abnormal” hair analysis results.
Although we cannot trace this develop-
ment to the Internet and have not attempted
to quantify the number, we have observed an
increase in the number of patients coming to
our clinic with concern for their health fol-
lowing hair analysis. These three cases are typ-
ical. In each of the three cases, the patient
presented with nonspeciﬁc complaints such as
joint pain, muscle aches, fatigue, flu-like
symptoms, constipation, loss of appetite, and
headache, but lacked objective evidence of ill-
ness. They had diagnoses such as ﬁbromyal-
gia, chronic fatigue syndrome, irritable bowel
syndrome, anxiety, and depression. In addi-
tion, the patients had been diagnosed with
metal toxicity based on hair analysis and other
diagnostic tests, and were either treated with
chelation therapy or believed that chelation
therapy was required. In each case, hair analy-
sis results obtained before coming to our prac-
tice were reported to be elevated, whereas the
additional tests used were within normal lim-
its (e.g., lead chelation challenge) or were dif-
ficult to interpret (e.g., lead level in packed
erythrocytes, spot urine samples for lead). 
In case 1, despite the patient’s elevated
hair mercury level and DMSA challenge, we
did not feel that this patient was suffering
from mercury toxicity. The patient’s history
revealed a lack of significant environmental
or occupational exposure to mercury, and her
physical exam was within normal limits. We
also did not believe that the urine test follow-
ing a DMSA challenge (11.5 µg/g creatinine)
was consistent with toxicity. Although there
is a lack of normative data for provocative
DMSA challenges for mercury, which makes
her results difficult to interpret (2), data
regarding unstimulated urine tests suggest
that her results did not reflect toxicity. In
unexposed populations, a normal mercury
urine concentration is < 10 µg/g creatinine.
Subtle neurologic effects are observed at uri-
nary mercury levels > 20 µg/L and early renal
effects are observed at levels > 50 µg/g creati-
nine (3,4). Therefore, we felt that the result
of this patient’s provocative challenge was rel-
atively low and did not reﬂect mercury toxic-
ity. The diagnosis of mercury toxicity is
typically made from testing blood or urine
(5). In this patient, a blood test obtained in
our clinic resulted in a mercury level of 11
µg/L (1.1 µg/100 mL). According to the
Agency for Toxic Substances and Disease
Registry, normal levels for mercury in blood
range from 0.5 to 2.0 µg/100 mL (6).
In case 2, the patient was also concerned
about mercury toxicity and had begun chela-
tion therapy in the form of Captomer.
Captomer is sold in 100-mg tablets, of which
65 mg is succinic acid (7). Captomer or other
forms of DMSA can be purchased over the
Internet (8). Many alternative medicine Web
sites offer DMSA for “detoxification” (9).
Patient 2 also had 12 dental amalgam ﬁllings
removed. We assessed that, although this
patient’s mercury levels were higher than
would be expected in the general population,
these levels did not warrant chelation therapy
or removal of amalgams. Rather, we believed
that this patient’s mercury elevation was most
likely due to her fish consumption, which
ranged from four to six servings per week. In
studies of persons who reported eating fish
more than four times per week, the mean
whole blood mercury level was 4.44 µg/100
mL (44.4 µg/L) (10), a level entirely consis-
tent with this patient’s history. In addition,
symptoms relating to mercury toxicity in per-
sons with occupational exposure are more
likely to occur at blood levels in excess of 200
µg/L (10), which is considerably higher than
this patient’s results. We therefore recom-
mended to this patient that she decrease her
ﬁsh intake to no more than one serving per
week and that she have another blood level
measured in 1–2 months. She did not return
for a repeat measurement. 
In case 3, the patient had received intra-
venous EDTA for 2.5 years. It was our
assessment that the patient was not suffering
from lead toxicity and that chelation was not
warranted. His physical examination was
within normal limits, and his laboratory
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provocative challenge, such as the patient
received, is appropriate for determining
chelatable lead burden. Typically, values
> 600 µg/24 hr are considered evidence of
an elevated chelatable-lead burden (11). The
patient’s values never exceeded 22 µg/24 hr,
however. In our view, spot urine samples
and packed erythrocytes for lead, as per-
formed on this patient, are less useful than
measurement of blood lead and chelatable-
lead in evaluating patients (10,11), mainly
because of inherent difﬁculties with interpre-
tation of these measures. 
In addition to concerns about the diag-
noses these patients had received, we were
concerned about their treatment in these set-
tings. These patients all sought or were
already receiving chelation therapy. Chelation
therapy has not been shown to improve out-
comes in patients with the clinical presenta-
tions described and the low levels of mercury
seen in cases 1 and 2 (12). There is some evi-
dence that chelation in patients with renal
insufﬁciency and low-to-moderate chelatable-
lead levels improves creatinine clearance over
time (13), but patient 3 did not have renal
insufﬁciency and his lead level was lower than
those described by Lin et al. (13). In view of
the lack of evidence on the efﬁcacy and safety
of chelation treatment in patients with low-
to-moderate metal exposures, removal of the
individual from the exposure is the therapeu-
tic approach most favored (12). This is the
approach we followed with patient 2 when we
recommended reduction in ﬁsh consumption. 
In these three cases, the treatments pro-
vided were homeopathic at best (DMSA) and
possibly detrimental at worst (intravenous
EDTA). The homeopathic nature of patient
2’s treatment is demonstrated by comparing
the dose of Captomer that she was taking
with the recommended dose of succimer (also
contains DMSA) for patients with mercury
toxicity. One Captomer pill contains 65 mg
of succinic acid. Patient 2 was taking three
Captomer pills per day initially, and later
three pills per week. By contrast, the recom-
mended dose of Succimer for mercury intoxi-
cation is 30 mg/kg/day or 1,500 mg/day for a
50 kg woman for 5 days (14). Patient 3
received intravenous EDTA for 2.5 years.
This treatment exposed him to the potential
side effects of EDTA without evidence of the
possibility of clear clinical beneﬁt.
As discussed above, a common theme to
these patients’ case histories was the role of
hair analysis in the diagnosis of metal toxic-
ity. It should be noted that hair analysis can
be useful in certain settings. Research studies
using validated methods can effectively
assess methymercury levels of a population
(15). Mercury and arsenic poisoning have
also been documented with the use of hair
analysis (16,17). 
It is important to distinguish the use of
hair metal analysis in a research setting (in
which one or a few analytes are measured in
individuals in a deﬁned population to make
inferences in that population) from the use
of a panel of hair metal measurements to
make a diagnosis in an individual patient.
This is particularly true with patients whose
symptoms and exposure history may suggest
a low likelihood of metal toxicity; if the
pretest probability of disease is low, the
probability that a positive test is a false posi-
tive result can become substantial (18). In
addition, each of our patients had an exten-
sive panel of mineral and toxicant levels
(consisting of 34–39 analytes) measured in
their hair. Assuming that test results are
independent of one another, testing 34–39
different minerals and toxicants instead of 1
greatly increases the chances that any one of
these test results will be elevated by chance
alone. For example, if the 95th percentile of
the distribution is selected as the criterion
for an abnormal test and the analyte results
are independent, then the chance that at
least 1 analyte in a panel of 34 will be ele-
vated based on chance alone is approxi-
mately 83% {i.e., [1 – (0.95)34]} (19).
Several studies over the past few decades
have demonstrated the limited utility of hair
analysis as a diagnostic tool. Seidel et al. (17)
recently reported a comparison of hair analy-
sis results in six commercial laboratories. In
their paper they concluded that “hair mineral
analysis from these laboratories was unreli-
able,” and recommended “that health care
practitioners refrain from using such analyses
to assess individual nutritional status or sus-
pected environmental exposures” (p. 67).
Indeed, the medical literature makes plain
that physicians should not rely solely on hair
analysis to diagnose or treat heavy metal toxi-
city or nutritional deﬁciencies because these
tests are unreliable and have poorly 
established reference ranges (17,20,21).
Accordingly, occupational and environmen-
tal physicians have cautioned that making
treatment decisions on the basis of hair analy-
sis can result in adverse medical and public
health consequences, such as unnecessary and
potentially dangerous treatments and need-
less worry on the part of patients (22). 
Clinicians examining patients who
believe they are suffering from metal toxicity
because of hair analysis results should be pre-
pared to discuss with their patients the rea-
sons why the hair analysis may not serve as a
reliable diagnostic tool in individual cases.
Some of the concerns that researchers have
raised regarding hair analysis as a diagnostic
tool include lack of validation of analytical
techniques, presence of exogenous contami-
nants, and variable analytic procedures and
low interlaboratory reliability. These factors,
coupled with the fact that reference values
are not well-established, mitigate against the
use of such testing in individual patients pre-
senting with nonspecific, multisystemic
symptoms. 
Lack of validation of analytic techniques.
Seidel et al. (17) reported that laboratories
vary greatly with regard to the standards used
for validation, quality assurance, and quality
control. Calibration standards include the use
of non-hair mineral standards, pooled in-
house hair samples, and the use of “Chinese
commercial hair standard(s) certiﬁed for up to
17 elements” (p. 68). There is no standard
certiﬁcation for metals analyzed. 
Presence of exogenous contaminants. Hair
provides an effective medium for binding
material such as dust and sweat (23).
Exogenous contaminants can make hair
analysis highly inaccurate because it is
unclear whether the source of the mineral is
endogenous or exogenous. Sources of conta-
mination include sweat and sebacious secre-
tions, dust, and beauty treatments such as
shampoos, conditioners, permanent waves,
bleaches, and hair spray (24). Sky-Peck (25)
compared natural hair to hair treated with
peroxide or with permanents and showed
that treatments signiﬁcantly altered the con-
centration of sulfur, calcium, iron, and
nickel. In addition, hair treatments affect
zinc, copper, and arsenic concentrations (25).
Others have shown significant effects of
beauty treatments on zinc and copper con-
centration (21). Klevay et al. (26) reported a
list of 16 elements whose concentrations in
hair can be affected by grooming products.
Many different washing procedures have
been described and numerous studies have
been carried out to determine which method
is most effective. These procedures include
the use of organic solvents, ionic and non-
ionic detergents, chelating agents, rinses with
deionized water, hot solutions, ultrasoniﬁca-
tion, dilute acid, and cold distilled water
(23). Seidel et al. (17) reported that the
washing methods differ greatly among labo-
ratories, with some laboratories not washing
at all; this illustrates the lack of consensus on
the best washing technique (17). Despite
efforts by the American Medical Association
(27), the International Atomic Agency (23),
individual laboratories, and groups of labora-
tories (Society for Elemental Laboratory
Testing), approaches to washing among lab-
oratories continue to vary (27).
Variable analytic procedure and low
interlaboratory reliability. Differing analytic
procedures contribute to the discrepancies
observed among different laboratories.
Although many analytic procedures have been
described, the two most commonly used
today, based on a recent survey, are ICP-MS
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emission spectrometry (ICP-AES) (17). ICP-
MS has been shown to be more sensitive at
detecting the lower limits of trace elements
and less likely to provide discrepant reference
levels than ICP-AES (28). 
Several studies over the years have per-
formed interlaboratory comparisons. In
1982, Mason and Zlotkin (29) reported a
study in which hair samples from three
healthy men were sent to three laboratories.
In 1985, Barrett (20) reported on samples
from two healthy teenagers that were sent to
13 laboratories. Sixteen years later, Seidel et
al. (17) described a study in which a hair
sample from a healthy individual was sub-
mitted for analysis to six different laborato-
ries. All of these studies found substantial
interlaboratory variability. 
It has been estimated that 225,000 hair
mineral tests are performed each year in the
United States by the nine leading commer-
cial laboratories, at an average annual cost of
approximately $9.6 million (17). However,
this estimate undervalues the costs to society
because it does not include the cost of addi-
tional unnecessary diagnostic tests, unneces-
sary treatment, and adverse outcomes that
ensue. The three patients described above,
for example, received unnecessary diagnostic
tests and unnecessary treatment, although
fortunately, there were no apparent adverse
outcomes.
Conclusion
We have presented three patients who came
to our clinic after having received diagnoses
of metal toxicity based, at least in part, on
the results of hair analysis. All three patients
initially presented to outside physicians for
evaluation of nonspecific, multisystemic
symptoms. Occupational and environmen-
tal history, medical history, and physical
examination suggested that the likelihood of
metal toxicity as the cause of the symptoms
was low. In the case of these three patients,
laboratories measured a panel of analytes in
hair and reported that one or more analytes
were elevated. Environmental and occupa-
tional physicians should be aware that some
patients who are concerned about metal toxi-
city may ask about hair analysis or may
already have had hair analysis performed.
Hair analysis should be used with caution to
make decisions regarding overexposure or
need for treatment in patients with nonspe-
ciﬁc symptoms and a low pretest probability
of metal toxicity based on medical history,
exposure history, and physical examination.
Physicians should be prepared to explain to
patients the reasons that hair analysis is not a
reliable indicator of exposure in this setting.
Finally, physicians should counsel patients to
stop treatment if they are already being
treated for metal toxicity based on hair analy-
sis and other unconventional diagnostic tests. 
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